Drug Trial Radar · NCT06175351
Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Last checked: Nov 20, 2026Latest source record: May 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Jul 6, 2023
Primary completion
Sep 30, 2025
Study completion Sep 30, 2025
Sponsor
- Lead sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the pharmacokinetic characteristics, safety, tolerability, and preliminary efficacy of 9MW1911 in combination with standard of care COPD maintenance therapy in patients with moderate to severe COPD.
Conditions
- Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Interventions
9MW1911Drug
Participants will receive IV 9MW1911 every 4 weeks.
PlaceboDrug
Participants will receive IV placebo every 4 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetic characteristics.Time frame: 36 weeks
- Pharmacokinetic characteristics.Time frame: 36 weeks
- Pharmacokinetic characteristics.Time frame: 36 weeks
- Pharmacokinetic characteristics.Time frame: 36 weeks
- Pharmacokinetic characteristics.Time frame: 36 weeks
- Pharmacokinetic characteristics.Time frame: 36 weeks
- Safety and tolerabilityTime frame: 36 weeks
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Baogang Hospital (No 3 Hospital Affiliated to Medical College of Inner Mongolia)
Baotou, China
China-Japan Friendship Hospital
Beijing, China
Peking University Shougang Hospital
Beijing, China
The First Hospital of Changsha
Changsha, China
The second xiangya hospital of central south university
Changsha, China
Chengdu Fifth People's Hospital
Chengdu, China
Chongqing Red Cross Hospital (People's Hospital of Jiangbei District)
Chongqing, China
Fu Yang People's Hospital
Fuyang, China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
The Third Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
The Second Hospital, University of South China
Hengyang, China
The Third People's Hospital of Huizhou
Huizhou, China
Jiangmen Central Hospital
Jiangmen, China
Liaocheng People's Hospital
Liaocheng, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
Pingxiang People's Hospital
Pingxiang, China
The First Affiliated Hospital of Qiqihar Medical University
Qiqihar, China
Tongji Hospital of Tongji University
Shanghai, China
Shengjing Hospital of China Medical University
Shenyang, China
Suzhou Municipal Hospital
Suzhou, China
The First Hospital of Shanxi Medical University
Taiyuan, China
Taizhou Hospital of Zhejiang Province
Taizhou, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.